| Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade QU Zhang, J Luo, S Wu, H Si, C Gao, W Xu, SE Abdullah, BW Higgs, ... Cancer discovery 10 (12), 1842-1853, 2020 | 244 | 2020 |
| Five-factor prognostic model for survival of post-platinum patients with metastatic urothelial carcinoma receiving PD-L1 inhibitors G Sonpavde, J Manitz, C Gao, D Tayama, C Kaiser, D Hennessy, ... The Journal of urology 204 (6), 1173-1179, 2020 | 66 | 2020 |
| Estimation of multiple networks in Gaussian mixture models C Gao, Y Zhu, X Shen, W Pan Electronic journal of statistics 10, 1133, 2016 | 46 | 2016 |
| Durvalumab activity in previously treated patients who stopped durvalumab without disease progression S Sheth, C Gao, N Mueller, P Martinez, JC Soria Annals of Oncology 30, v475-v476, 2019 | 33 | 2019 |
| Safety and clinical activity of durvalumab monotherapy in patients with microsatellite instability–high (MSI-H) tumors. NH Segal, ZA Wainberg, MJ Overman, PA Ascierto, HT Arkenau, ... Journal of Clinical Oncology 37 (4_suppl), 670-670, 2019 | 32 | 2019 |
| Early incidence of immune-related adverse events (irAEs) predicts efficacy in patients (pts) with solid tumors treated with immune-checkpoint inhibitors (ICIs). C Morehouse, SE Abdullah, C Gao, MM Dar, K Ranade, BW Higgs Journal of Clinical Oncology 37 (15_suppl), 2563-2563, 2019 | 7 | 2019 |
| Abstract OT-03-05: Trastuzumab deruxtecan (T-DXd; DS-8201) in combination with other anticancer agents in patients with HER2-low metastatic breast cancer: A phase 1b, open … K Jhaveri, E Hamilton, S Loi, P Schmid, A Darilay, C Gao, G Patel, ... Cancer Research 81 (4_Supplement), OT-03-05-OT-03-05, 2021 | 6 | 2021 |
| 5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors. G Sonpavde, J Manitz, C Gao, D Hennessy, D Makari, G Niegisch, ... Journal of Clinical Oncology 37 (15_suppl), 4552-4552, 2019 | 4 | 2019 |
| Adaptive testing of SNP-brain functional connectivity association via a modular network analysis C Gao, J Kim, W Pan, Alzheimer's Disease Neuroimaging Initiative PACIFIC SYMPOSIUM ON BIOCOMPUTING 2017, 58-69, 2017 | 4 | 2017 |
| Trastuzumab deruxtecan (T-DXd; DS-8201) in combination with other anticancer agents in patients with HER2-low metastatic breast cancer: a phase 1b, open-label, multicenter … K Jhaveri, E Hamilton, S Loi, P Schmid, A Darilay, C Gao, G Patel, ... Cancer Research 81 (4), 2021 | 2 | 2021 |
| 674 Late antibiotic administration during durvalumab treatment may be associated with clinical benefit S Sheth, C Morehouse, E Dozier, C Gao, P Warrener, V Gopalakrishnan, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 1 | 2020 |
| FIVE-FACTOR PROGNOSTIC MODEL FOR SURVIVAL OF POST-PLATINUM PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA RECEIVING PD-L1 INHIBITORS (vol 204, pg 1173, 2020) G Sonpavde, J Manitz, C Gao, D Tayama, C Kaiser, D Hennessy, ... JOURNAL OF UROLOGY 205 (3), 942-942, 2021 | | 2021 |
| Prediction of overall survival in urothelial cancer patients using tumor sizes and baseline risk factors: longitudinal modeling approach for durvalumab and durvalumab+ tremelimumab M Tang, Y Jiang, H Si, Y Zheng, C Gao, G Gao, N Angra, S Abdullah, ... Cancer Research 79 (13_Supplement), 3158-3158, 2019 | | 2019 |
| Molecular circulating tumor DNA response to identify long-term survival in patients receiving immunotherapy with initial radiologic stable disease. MD Hellmann, Q Zhang, SE Abdullah, JE Chaft, NH Segal, C Gao, ... Journal of Clinical Oncology 37 (15_suppl), 2546-2546, 2019 | | 2019 |
